Reversible bone deformities in a severe case of uremic Leontiasis Ossea

This is a preview of subscription content, access via your institution.

Fig. 1


  1. 1.

    Kumar S, Thuraisingham R, Yaqoob M (2006) Big-head disease: uremic leontiasis ossea. Kidney Int 69(10):1709

    CAS  Article  Google Scholar 

  2. 2.

    Zhang L, Yao L, Bian WJ, Rui HL (2009) Severe uremic leontiasis ossea ameliorated by total parathyroidectomy. Kidney Int 76(10):1118

    Article  Google Scholar 

  3. 3.

    Donoso-Hofer F, Gunther-Wood M, Romero-Romano P, Pezoa-Opazo N, Fernández-Toro MA, Ortega-Pinto AV (2018) Uremic leontiasis ossea, a rare presentation of severe renal osteodystrophy secondary to hyperparathyroidism. J Stomatol Oral Maxillofac Surg 119(1):56–60

    CAS  Article  Google Scholar 

  4. 4.

    Giray S, Sagliker Y, Yildiz I et al (2006) Neurologic manifestations in Sagliker syndrome: uglifying human face appearance in severe and late secondary hyperparathyroidism in chronic renal failure patients. J Ren Nutr 16(3):233–236

    Article  Google Scholar 

  5. 5.

    Yang G, Zhang B, Zha XM, Wang NN, Xing CY (2014) Total parathyroidectomy with autotransplantation for a rare disease derived from uremic secondary hyperparathyroidism, the uremic leontiasis ossea. Osteoporos Int 25(3):1115–1121

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Clément Gosset.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Ethical apprpoval

This article reports the clinical case of a patient but no experimental research. The exams which led to the diagnosis and the therapeutic management belongs to routine care. As stated in the manuscript, the patient gave consent for publication as requested by Helsinki declaration and the Journal of nephrology submission gudelines.

Consent for publication

The patient whose case is reported gave oral and written consent for publication.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary Figure

Biological outcomes and treatment over time. (A.) Alkaline phosphatase (ALP) and bone ALP (bALP); (B.) Calcium (Ca), ionized Calcium (iCa), and phosphorus (Ph); (C.) Parathormone level (PTH). (D.) Daily Alfacacidiol supplementation; (E.) Daily Cinacalcet intake; (F.) Weekly calcium intake. Vertical dotted line represents the time of total parathyroidectomy (PTX). * above laboratory upper threshold. (PDF 69 KB)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tassin, C., Moscatelli, L., Di Ascia, L. et al. Reversible bone deformities in a severe case of uremic Leontiasis Ossea. J Nephrol (2021).

Download citation


  • End stage renal disease
  • Chronic kidney disease-mineral and bone disorder
  • Uremic Leontiasis Ossea
  • Parathyroidectomy